171 related articles for article (PubMed ID: 31045756)
1. Zygomatic bone metastasis from hepatocellular carcinoma and the therapeutic efficacy of apatinib: A case report and literature review.
Lei Q; Chen H; Zheng H; Deng F; Wang F; Li J; Hu J; Fu R; Zhen Z
Medicine (Baltimore); 2019 May; 98(18):e14595. PubMed ID: 31045756
[TBL] [Abstract][Full Text] [Related]
2. Zygomatic bone metastasis as an initial presentation of hepatocellular carcinoma.
Tomanovic N; Krstic A; Brasanac D; Dimitrijevic M; Terzic T; Boricic I
Arch Iran Med; 2013 Nov; 16(11):675-8. PubMed ID: 24206412
[TBL] [Abstract][Full Text] [Related]
3. Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
BMC Cancer; 2013 Jun; 13():306. PubMed ID: 23800357
[TBL] [Abstract][Full Text] [Related]
4. The excellent antitumor effect of apatinib alone as second-line therapy in a patient with sorafenib-refractory hepatocellular carcinoma: A case report.
Zhu H; Ma X; Zhao Y; Duo J
Medicine (Baltimore); 2018 Jun; 97(25):e11214. PubMed ID: 29924049
[TBL] [Abstract][Full Text] [Related]
5. Apatinib treatment of advanced hepatocellular carcinoma with portal vein and inferior vena cava tumor thrombus: A case report.
Yang X; Wu G; Xu G
Medicine (Baltimore); 2019 Feb; 98(8):e14582. PubMed ID: 30813176
[TBL] [Abstract][Full Text] [Related]
6. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
7. Significant Efficacy of Apatinib in a Patient With Hepatocellular Carcinoma Lung Metastases After Liver Transplantation: A Case Report.
Yu Z; Liu W; Deng Y; Yao J; Tang H; Li H; Yang Y; Wang G; Chen G
Transplant Proc; 2018 Dec; 50(10):4042-4045. PubMed ID: 30577311
[TBL] [Abstract][Full Text] [Related]
8. The effect of apatinib in the treatment of sorafenib resistant metastatic hepatocellular carcinoma: A case report.
Han Z; He Z; Wang C; Wang Q
Medicine (Baltimore); 2018 Dec; 97(49):e13388. PubMed ID: 30544412
[TBL] [Abstract][Full Text] [Related]
9. Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.
Yang C; Qin S
Cancer Med; 2018 Sep; 7(9):4570-4583. PubMed ID: 30109780
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
11. Radiomics Signature: A potential biomarker for the prediction of survival in Advanced Hepatocellular Carcinoma.
Li L; Kan X; Zhao Y; Liang B; Ye T; Yang L; Zheng C
Int J Med Sci; 2021; 18(11):2276-2284. PubMed ID: 33967603
[No Abstract] [Full Text] [Related]
12. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
[TBL] [Abstract][Full Text] [Related]
13. Increase in serum alpha-fetoprotein without recurrent disease after hepatectomy for hepatocellular carcinoma.
Cristani A; Cioni G; De Santis M; Chianese L; Gozzetti G; Ventura E
Hepatogastroenterology; 1994 Apr; 41(2):137-9. PubMed ID: 7520014
[TBL] [Abstract][Full Text] [Related]
14. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
[TBL] [Abstract][Full Text] [Related]
15. Histological differentiation predicts post-liver transplantation survival time.
Li WX; Li Z; Gao PJ; Gao J; Zhu JY
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):201-8. PubMed ID: 24388339
[TBL] [Abstract][Full Text] [Related]
16. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
17. [A case of hepatocellular carcinoma with bone metastasis responding to concurrent TS-1/low-dose cisplatin (CDDP) therapy and radiotherapy].
Suganuma T; Terauchi R; Shikina A; Tanaka M; Aozasa S; Utsunomiya K; Fujino K; Ito H; Okada K; Tsuda T; Hase K
Gan To Kagaku Ryoho; 2004 May; 31(5):781-4. PubMed ID: 15170993
[TBL] [Abstract][Full Text] [Related]
18. Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case report and literature review.
Kou P; Zhang Y; Shao W; Zhu H; Zhang J; Wang H; Kong L; Yu J
Oncotarget; 2017 Mar; 8(12):20510-20515. PubMed ID: 28103584
[TBL] [Abstract][Full Text] [Related]
19. α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.
Kamiyama T; Takahashi M; Nakanishi K; Yokoo H; Kamachi H; Kobayashi N; Ozaki M; Todo S
World J Gastroenterol; 2012 Jan; 18(4):340-8. PubMed ID: 22294840
[TBL] [Abstract][Full Text] [Related]
20. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
